{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:48:26Z","timestamp":1775260106180,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":66,"publisher":"Springer US","isbn-type":[{"value":"9781071648476","type":"print"},{"value":"9781071648483","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-4848-3_1","type":"book-chapter","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:14:17Z","timestamp":1762164857000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computer-Aided Discovery of Drugs Against Chagas Disease"],"prefix":"10.1007","author":[{"given":"Carolina L.","family":"Bellera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas N.","family":"Alberca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Talevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.3390\/molecules25122799","volume":"25","author":"AF Francisco","year":"2020","unstructured":"Francisco AF, Jayawardhana S, Olmo F et al (2020) Challenges in Chagas disease drug development. Molecules 25:2799. https:\/\/doi.org\/10.3390\/molecules25122799","journal-title":"Molecules"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/17460441.2024.2349155","volume":"19","author":"SMF Murta","year":"2024","unstructured":"Murta SMF, Lemos Santana PA, Jacques Dit Lapierre TJW et al (2024) New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease. Expert Opin Drug Discov 19:741\u2013753. https:\/\/doi.org\/10.1080\/17460441.2024.2349155","journal-title":"Expert Opin Drug Discov"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/ph16060891","volume":"16","author":"A Blanco-Gonz\u00e1lez","year":"2023","unstructured":"Blanco-Gonz\u00e1lez A, Cabez\u00f3n A, Seco-Gonz\u00e1lez A et al (2023) The role of AI in drug discovery: challenges, opportunities, and strategies. Pharmaceuticals (Basel) 16:891. https:\/\/doi.org\/10.3390\/ph16060891","journal-title":"Pharmaceuticals (Basel)"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ipha.2024.02.009","volume":"2","author":"S Yadav","year":"2024","unstructured":"Yadav S, Singh A, Singhal R et al (2024) Revolutionizing drug discovery: the impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry. Intelligent Pharmacy 2:367\u2013380. https:\/\/doi.org\/10.1016\/j.ipha.2024.02.009","journal-title":"Intelligent Pharmacy"},{"key":"1_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ailsci.2022.100049","volume":"2","author":"DN Prada Gori","year":"2022","unstructured":"Prada Gori DN, Alberca LN, Rodr\u00edguez S et al (2022) LIDeB tools: a Latin American resource of freely available, open-source cheminformatics apps. Artif Intell Life Sci 2:100049. https:\/\/doi.org\/10.1016\/j.ailsci.2022.100049","journal-title":"Artif Intell Life Sci"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/17460441.2024.2355330","volume":"19","author":"CRC Calado","year":"2024","unstructured":"Calado CRC (2024) Bridging the gap between target-based and phenotypic-based drug discovery. Expert Opin Drug Discov 19:789\u2013798. https:\/\/doi.org\/10.1080\/17460441.2024.2355330","journal-title":"Expert Opin Drug Discov"},{"key":"1_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305608","volume":"11","author":"Y Gao","year":"2024","unstructured":"Gao Y, Ma M, Li W et al (2024) Chemoproteomics, a broad avenue to target deconvolution. Adv Sci (Weinh) 11:e2305608. https:\/\/doi.org\/10.1002\/advs.202305608","journal-title":"Adv Sci (Weinh)"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41573-020-0087-3","volume":"20","author":"CH Emmerich","year":"2021","unstructured":"Emmerich CH, Gamboa LM, Hofmann MCJ et al (2021) Improving target assessment in biomedical research: the GOT-IT recommendations. Nat Rev Drug Discov 20:64\u201381. https:\/\/doi.org\/10.1038\/s41573-020-0087-3","journal-title":"Nat Rev Drug Discov"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrd4309","volume":"13","author":"D Cook","year":"2014","unstructured":"Cook D, Brown D, Alexander R et al (2014) Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: a five-dimensional framework. Nat Rev Drug Discov 13:419\u2013431. https:\/\/doi.org\/10.1038\/nrd4309","journal-title":"Nat Rev Drug Discov"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.drudis.2020.10.019","volume":"26","author":"SS Wu","year":"2021","unstructured":"Wu SS, Fernando K, Allerton C et al (2021) Reviving an R&D pipeline: a step change in the phase II success rate. Drug Discov Today 26:308\u2013314. https:\/\/doi.org\/10.1016\/j.drudis.2020.10.019","journal-title":"Drug Discov Today"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","volume":"162","author":"JP Hughes","year":"2011","unstructured":"Hughes JP, Rees S, Kalindjian SB et al (2011) Principles of early drug discovery. Br J Pharmacol 162:1239\u20131249. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01127.x","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"1_CR12","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1471-2377-9-S1-S2","volume":"9","author":"KL Steinmetz","year":"2009","unstructured":"Steinmetz KL, Spack EG (2009) The basics of preclinical drug development for neurodegenerative disease indications. BMC Neurol 9(Suppl 1):S2. https:\/\/doi.org\/10.1186\/1471-2377-9-S1-S2","journal-title":"BMC Neurol"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/17460441.2020.1704729","volume":"15","author":"A Talevi","year":"2020","unstructured":"Talevi A, Bellera CL (2020) Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics. Expert Opin Drug Discov 15:397\u2013401. https:\/\/doi.org\/10.1080\/17460441.2020.1704729","journal-title":"Expert Opin Drug Discov"},{"key":"1_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030239","volume":"6","author":"LL Silver","year":"2016","unstructured":"Silver LL (2016) Appropriate targets for antibacterial drugs. Cold Spring Harb Perspect Med 6:a030239. https:\/\/doi.org\/10.1101\/cshperspect.a030239","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.2174\/0929867325666180926151059","volume":"26","author":"A Talevi","year":"2019","unstructured":"Talevi A, Carrillo C, Comini M (2019) The thiol-polyamine metabolism of Trypanosoma cruzi: molecular targets and drug repurposing strategies. Curr Med Chem 26:6614\u20136635. https:\/\/doi.org\/10.2174\/0929867325666180926151059","journal-title":"Curr Med Chem"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.2174\/156802611795429185","volume":"11","author":"PG Wyatt","year":"2011","unstructured":"Wyatt PG, Gilbert IH, Read KD et al (2011) Target validation: linking target and chemical properties to desired product profile. Curr Top Med Chem 11:1275\u20131283. https:\/\/doi.org\/10.2174\/156802611795429185","journal-title":"Curr Top Med Chem"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1128\/EC.05114-11","volume":"10","author":"NG Kolev","year":"2011","unstructured":"Kolev NG, Tschudi C, Ullu E (2011) RNA interference in protozoan parasites: achievements and challenges. Eukaryot Cell 10:1156\u20131163. https:\/\/doi.org\/10.1128\/EC.05114-11","journal-title":"Eukaryot Cell"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/jeu.12747","volume":"66","author":"N Lander","year":"2019","unstructured":"Lander N, Chiurillo MA (2019) State-of-the-art CRISPR\/Cas9 technology for genome editing in trypanosomatids. J Eukaryot Microbiol 66:981\u2013991. https:\/\/doi.org\/10.1111\/jeu.12747","journal-title":"J Eukaryot Microbiol"},{"key":"1_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00738-21","volume":"9","author":"MA Chiurillo","year":"2021","unstructured":"Chiurillo MA, Jensen BC, Docampo R (2021) Drug target validation of the protein kinase aek1, essential for proliferation, host cell invasion, and intracellular replication of the human pathogen Trypanosoma cruzi. Microbiol Spectr 9:e0073821. https:\/\/doi.org\/10.1128\/Spectrum.00738-21","journal-title":"Microbiol Spectr"},{"key":"1_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/597913","volume":"2008","author":"R Moreno-S\u00e1nchez","year":"2008","unstructured":"Moreno-S\u00e1nchez R, Saavedra E, Rodr\u00edguez-Enr\u00edquez S et al (2008) Metabolic control analysis: a tool for designing strategies to manipulate metabolic pathways. J Biomed Biotechnol 2008:597913. https:\/\/doi.org\/10.1155\/2008\/597913","journal-title":"J Biomed Biotechnol"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbagen.2014.10.029","volume":"1850","author":"Z Gonz\u00e1lez-Ch\u00e1vez","year":"2015","unstructured":"Gonz\u00e1lez-Ch\u00e1vez Z, Olin-Sandoval V, Rod\u00edguez-Zavala JS et al (2015) Metabolic control analysis of the Trypanosoma cruzi peroxide detoxification pathway identifies tryparedoxin as a suitable drug target. Biochim Biophys Acta 1850:263\u2013273. https:\/\/doi.org\/10.1016\/j.bbagen.2014.10.029","journal-title":"Biochim Biophys Acta"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acsinfecdis.9b00484","volume":"6","author":"S Davoodi","year":"2020","unstructured":"Davoodi S, Daryaee F, Chang A et al (2020) Correlating drug-target residence time and post-antibiotic effect: insight into target vulnerability. ACS Infect Dis 6:629\u2013636. https:\/\/doi.org\/10.1021\/acsinfecdis.9b00484","journal-title":"ACS Infect Dis"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nrd2275","volume":"6","author":"J Owens","year":"2007","unstructured":"Owens J (2007) Determining druggability. Nat Rev Drug Discov 6:187. https:\/\/doi.org\/10.1038\/nrd2275","journal-title":"Nat Rev Drug Discov"},{"key":"1_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-95895-4_5","volume-title":"Drug target selection and validation. Computer-aided drug discovery and design","author":"S Rodr\u00edguez","year":"2022","unstructured":"Rodr\u00edguez S, Alice JI, Bellera CL et al (2022) Structure-based binding pocket detection and druggability assessment. In: Scotti MT, Bellera CL (eds) Drug target selection and validation. Computer-aided drug discovery and design, vol 1. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-030-95895-4_5"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.1038\/s41598-022-12105-8","volume":"12","author":"L Alzyoud","year":"2022","unstructured":"Alzyoud L, Bryce RA, Al Sorkhy M et al (2022) Structure-based assessment and druggability classification of protein-protein interaction sites. Sci Rep 12:7975. https:\/\/doi.org\/10.1038\/s41598-022-12105-8","journal-title":"Sci Rep"},{"key":"1_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-05314-0_2","volume-title":"Small molecule \u2013 protein interactions. Ernst schering research foundation workshop","author":"AL Hopkins","year":"2003","unstructured":"Hopkins AL, Groom CR (2003) Target analysis: a priori assessment of druggability. In: Waldmann H, Koppitz M (eds) Small molecule \u2013 protein interactions. Ernst schering research foundation workshop, vol 42. Springer, Berlin, Heidelberg. https:\/\/doi.org\/10.1007\/978-3-662-05314-0_2"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1021\/acs.jcim.9b01209","volume":"60","author":"G Martinez-Rosell","year":"2020","unstructured":"Martinez-Rosell G, Lovera S, Sands ZA et al (2020) PlayMolecule CrypticScout: predicting protein cryptic sites using mixed-solvent molecular simulations. J Chem Inf Model 60:2314\u20132324. https:\/\/doi.org\/10.1021\/acs.jcim.9b01209","journal-title":"J Chem Inf Model"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/prot.26027","volume":"89","author":"W Zheng","year":"2021","unstructured":"Zheng W (2021) Predicting cryptic ligand binding sites based on normal modes guided conformational sampling. Proteins 89:416\u2013426. https:\/\/doi.org\/10.1002\/prot.26027","journal-title":"Proteins"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3389\/fchem.2019.00534","volume":"7","author":"LN Alberca","year":"2019","unstructured":"Alberca LN, Chuguransky SR, \u00c1lvarez CL et al (2019) In silico guided drug repurposing: discovery of new competitive and non-competitive inhibitors of Falcipain-2. Front Chem 7:534. https:\/\/doi.org\/10.3389\/fchem.2019.00534","journal-title":"Front Chem"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1021\/acs.jmedchem.7b01670","volume":"61","author":"AR Blaazer","year":"2018","unstructured":"Blaazer AR, Singh AK, de Heuvel E et al (2018) Targeting a subpocket in Trypanosoma brucei phosphodiesterase B1 (TbrPDEB1) enables the structure-based discovery of selective inhibitors with trypanocidal activity. J Med Chem 61:3870\u20133888. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01670","journal-title":"J Med Chem"},{"key":"1_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006483","volume":"14","author":"C Ehrt","year":"2018","unstructured":"Ehrt C, Brinkjost T, Koch O (2018) A benchmark driven guide to binding site comparison: an exhaustive evaluation using tailor-made data sets (ProSPECCTs). PLoS Comput Biol 14:e1006483. https:\/\/doi.org\/10.1371\/journal.pcbi.1006483","journal-title":"PLoS Comput Biol"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1039\/c9md00102f","volume":"10","author":"C Ehrt","year":"2019","unstructured":"Ehrt C, Brinkjost T, Koch O (2019) Binding site characterization \u2013 similarity, promiscuity, and druggability. Medchemcomm 10:1145\u20131159. https:\/\/doi.org\/10.1039\/c9md00102f","journal-title":"Medchemcomm"},{"issue":"6","key":"1_CR33","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/jac\/dkab063","volume":"76","author":"LH Galarion","year":"2021","unstructured":"Galarion LH, Mohamad M, Alzeyadi Z, Randall CP, O\u2019Neill AJ (2021) A platform for detecting cross-resistance in antibacterial drug discovery. J Antimicrob Chemother 76(6):1467\u20131471. https:\/\/doi.org\/10.1093\/jac\/dkab063","journal-title":"J Antimicrob Chemother"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10822-015-9860-5","volume":"29","author":"G Papadatos","year":"2015","unstructured":"Papadatos G, Gaulton A, Hersey A et al (2015) Activity, assay and target data curation and quality in the ChEMBL database. J Comput Aided Mol Des 29:885\u2013896. https:\/\/doi.org\/10.1007\/s10822-015-9860-5","journal-title":"J Comput Aided Mol Des"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1038\/s41596-023-00885-w","volume":"18","author":"VK Tran-Nguyen","year":"2023","unstructured":"Tran-Nguyen VK, Junaid M, Simeon S et al (2023) A practical guide to machine-learning scoring for structure-based virtual screening. Nat Protoc 18:3460\u20133511. https:\/\/doi.org\/10.1038\/s41596-023-00885-w","journal-title":"Nat Protoc"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3390\/molecules28041661","volume":"28","author":"F Pellicani","year":"2023","unstructured":"Pellicani F, Dal Ben D, Perali A et al (2023) Machine learning scoring functions for drug discovery from experimental and computer-generated protein-ligand structures: towards per-target scoring functions. Molecules 28:1661. https:\/\/doi.org\/10.3390\/molecules28041661","journal-title":"Molecules"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"D1633","DOI":"10.1093\/nar\/gkae1075","volume":"53","author":"T Liu","year":"2025","unstructured":"Liu T, Hwang L, Burley SK et al (2025) BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data. Nucleic Acids Res 53:D1633\u2013D1644. https:\/\/doi.org\/10.1093\/nar\/gkae1075","journal-title":"Nucleic Acids Res"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gkw1118","volume":"45","author":"Y Wang","year":"2017","unstructured":"Wang Y, Bryant SH, Cheng T et al (2017) PubChem BioAssay: 2017 update. Nucleic Acids Res 45:D955\u2013D963. https:\/\/doi.org\/10.1093\/nar\/gkw1118","journal-title":"Nucleic Acids Res"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2024","unstructured":"Zdrazil B, Felix E, Hunter F et al (2024) The ChEMBL database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res 52:D1180\u2013D1192. https:\/\/doi.org\/10.1093\/nar\/gkad1004","journal-title":"Nucleic Acids Res"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"1193282","DOI":"10.3389\/fphar.2023.1193282","volume":"14","author":"SM Ruatta","year":"2023","unstructured":"Ruatta SM, Prada Gori DN, Fl\u00f3 D\u00edaz M et al (2023) Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro. Front Pharmacol 14:1193282. https:\/\/doi.org\/10.3389\/fphar.2023.1193282","journal-title":"Front Pharmacol"},{"issue":"2","key":"1_CR41","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.0397","volume":"4","author":"JM Teno","year":"2023","unstructured":"Teno JM (2023) Garbage in, garbage out-words of caution on big data and machine learning in medical practice. JAMA Health Forum 4(2):e230397. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.0397","journal-title":"JAMA Health Forum"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"22329","DOI":"10.1038\/s41598-024-73643-x","volume":"14","author":"N Bhatt","year":"2024","unstructured":"Bhatt N, Bhatt N, Prajapati P et al (2024) A data-centric approach to improve performance of deep learning models. Sci Rep 14:22329. https:\/\/doi.org\/10.1038\/s41598-024-73643-x","journal-title":"Sci Rep"},{"key":"1_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.is.2025.102549","volume":"132","author":"S Mohammed","year":"2025","unstructured":"Mohammed S, Budach L, Feuerpfeil M et al (2025) The effects of data quality on machine learning performance on tabular data. Inf Syst 132:102549. https:\/\/doi.org\/10.1016\/j.is.2025.102549","journal-title":"Inf Syst"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/math11040820","volume":"11","author":"A Tharwat","year":"2023","unstructured":"Tharwat A, Schenck W (2023) A survey on active learning: state-of-the-art, practical challenges and research directions. Mathematics 11:820. https:\/\/doi.org\/10.3390\/math11040820","journal-title":"Mathematics"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1021\/ci100176x","volume":"50","author":"D Fourches","year":"2010","unstructured":"Fourches D, Muratov E, Tropsha A (2010) Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. J Chem Inf Model 50:1189\u20131204. https:\/\/doi.org\/10.1021\/ci100176x","journal-title":"J Chem Inf Model"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/acs.jcim.7b00505","volume":"57","author":"NO Friedrich","year":"2017","unstructured":"Friedrich NO, de Bruyn KC, Flachsenberg F et al (2017) Benchmarking commercial conformer ensemble generators. J Chem Inf Model 57:2719\u20132728. https:\/\/doi.org\/10.1021\/acs.jcim.7b00505","journal-title":"J Chem Inf Model"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.drudis.2014.02.003","volume":"19","author":"M Cruz-Monteagudo","year":"2014","unstructured":"Cruz-Monteagudo M, Medina-Franco JL, P\u00e9rez-Castillo Y et al (2014) Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde? Drug Discov Today 19:1069\u20131080. https:\/\/doi.org\/10.1016\/j.drudis.2014.02.003","journal-title":"Drug Discov Today"},{"key":"1_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cosrev.2020.100306","volume":"38","author":"A Smiti","year":"2020","unstructured":"Smiti A (2020) A critical overview of outlier detection methods. Comput Sci Rev 38:100306. https:\/\/doi.org\/10.1016\/j.cosrev.2020.100306","journal-title":"Comput Sci Rev"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1021\/acsomega.7b00274","volume":"2","author":"L Zhao","year":"2017","unstructured":"Zhao L, Wang W, Sedykh A et al (2017) Experimental errors in QSAR modeling sets: what we can do and what we cannot do. ACS Omega 2:2805\u20132812. https:\/\/doi.org\/10.1021\/acsomega.7b00274","journal-title":"ACS Omega"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1023\/A:1025386326946","volume":"17","author":"A Golbraikh","year":"2003","unstructured":"Golbraikh A, Shen M, Xiao Z et al (2003) Rational selection of training and test sets for the development of validated QSAR models. J Comput Aided Mol Des 17:241\u2013253. https:\/\/doi.org\/10.1023\/A:1025386326946","journal-title":"J Comput Aided Mol Des"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1021\/ci300338w","volume":"52","author":"TM Martin","year":"2012","unstructured":"Martin TM, Harten P, Young DM et al (2012) Does rational selection of training and test sets improve the outcome of QSAR modeling? J Chem Inf Model 52:2570\u20132578. https:\/\/doi.org\/10.1021\/ci300338w","journal-title":"J Chem Inf Model"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/qsar.200510161","volume":"25","author":"JT Leonard","year":"2006","unstructured":"Leonard JT, Roy K (2006) On selection of training and test sets for the development of predictive QSAR models. QSAR Comb Sci 25:235\u2013251. https:\/\/doi.org\/10.1002\/qsar.200510161","journal-title":"QSAR Comb Sci"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1039\/c8sc00148k","volume":"9","author":"A Mayr","year":"2018","unstructured":"Mayr A, Klambauer G, Unterthiner T et al (2018) Large-scale comparison of machine learning methods for drug target prediction on ChEMBL. Chem Sci 9:5441\u20135451. https:\/\/doi.org\/10.1039\/c8sc00148k","journal-title":"Chem Sci"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1021\/acs.jcim.8b00663","volume":"59","author":"A Lopez-Del Rio","year":"2019","unstructured":"Lopez-Del Rio A, Nonell-Canals A, Vidal D et al (2019) Evaluation of cross-validation strategies in sequence-based binding prediction using deep learning. J Chem Inf Model 59:1645\u20131657. https:\/\/doi.org\/10.1021\/acs.jcim.8b00663","journal-title":"J Chem Inf Model"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"1367537","DOI":"10.3389\/fntpr.2024.1367537","volume":"3","author":"A Talevi","year":"2024","unstructured":"Talevi A, Bellera CL (2024) Clustering of small molecules: new perspectives and their impact on natural product lead discovery. Front Nat Produc 3:1367537. https:\/\/doi.org\/10.3389\/fntpr.2024.1367537","journal-title":"Front Nat Produc"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/qsar.200390007","volume":"22","author":"A Tropsha","year":"2003","unstructured":"Tropsha A, Gramatica P, Gombar VK (2003) The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb Sci 22:69\u201377. https:\/\/doi.org\/10.1002\/qsar.200390007","journal-title":"QSAR Comb Sci"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2174\/138620711795767893","volume":"14","author":"K Roy","year":"2011","unstructured":"Roy K, Mitra I (2011) On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design. Comb Chem High Throughput Screen 14:450\u2013474. https:\/\/doi.org\/10.2174\/138620711795767893","journal-title":"Comb Chem High Throughput Screen"},{"key":"1_CR58","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1021\/ci050314b","volume":"46","author":"J Polanski","year":"2006","unstructured":"Polanski J, Bak A, Gieleciak R et al (2006) Modeling robust QSAR. J Chem Inf Model 46:2310\u20132318. https:\/\/doi.org\/10.1021\/ci050314b","journal-title":"J Chem Inf Model"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/qsar.200610151","volume":"26","author":"P Gramatica","year":"2007","unstructured":"Gramatica P (2007) Principles of QSAR models validation: internal and external. QSAR Comb Sci 26:694\u2013701. https:\/\/doi.org\/10.1002\/qsar.200610151","journal-title":"QSAR Comb Sci"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s1093-3263(01)00123-1","volume":"20","author":"A Golbraikh","year":"2002","unstructured":"Golbraikh A, Tropsha A (2002) Beware of q2! J Mol Graph Model 20:269\u2013276. https:\/\/doi.org\/10.1016\/s1093-3263(01)00123-1","journal-title":"J Mol Graph Model"},{"key":"1_CR61","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1021\/jm049092j","volume":"48","author":"N Triballeau","year":"2005","unstructured":"Triballeau N, Acher F, Brabet I et al (2005) Virtual screening workflow development guided by the \u201creceiver operating characteristic\u201d curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem 48:2534\u20132547. https:\/\/doi.org\/10.1021\/jm049092j","journal-title":"J Med Chem"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1021\/ci600426e","volume":"47","author":"JF Truchon","year":"2007","unstructured":"Truchon JF, Bayly CL (2007) Evaluating virtual screening methods: good and bad metrics for the \u201cearly recognition\u201d problem. J Chem Inf Model 47:488\u2013508. https:\/\/doi.org\/10.1021\/ci600426e","journal-title":"J Chem Inf Model"},{"key":"1_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ailsci.2025.100129","volume":"7","author":"LN Alberca","year":"2025","unstructured":"Alberca LN, Prado Gori DN, Fallico MJ et al (2025) LIDEB\u2019s useful decoys (LUDe): a freely available decoy-generation tool. Benchmarking and scope. Artif Intell Life Sci 7:100129. https:\/\/doi.org\/10.1016\/j.ailsci.2025.100129","journal-title":"Artif Intell Life Sci"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/minf.201000061","volume":"29","author":"A Trophsa","year":"2010","unstructured":"Trophsa A (2010) Best practices for QSAR model development, validation, and exploitation. Mol Inf 29:476\u2013488. https:\/\/doi.org\/10.1002\/minf.201000061","journal-title":"Mol Inf"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1039\/D2VA00225F","volume":"2","author":"J Gl\u00fcge","year":"2023","unstructured":"Gl\u00fcge J, McNeill K, Scheringer M (2023) Getting the SMILES right: identifying inconsistent chemical identities in the ECHA database, PubChem and the CompTox chemicals dashboard. Environ Sci Adv 2:612\u2013621. https:\/\/doi.org\/10.1039\/D2VA00225F","journal-title":"Environ Sci Adv"},{"key":"1_CR66","doi-asserted-by":"publisher","unstructured":"White A, Gibaldi M, Burner J et al (2024) Alarming structural error rates in MOF databases used in data driven workflows identified via a novel metal oxidation state-based method. ChemRxiv. https:\/\/doi.org\/10.26434\/chemrxiv-2024-ftsv3","DOI":"10.26434\/chemrxiv-2024-ftsv3"}],"container-title":["Methods in Molecular Biology","T. cruzi Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4848-3_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:30:28Z","timestamp":1775255428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4848-3_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"ISBN":["9781071648476","9781071648483"],"references-count":66,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4848-3_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"4 November 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}